Steven de Jong

9PUBLICATIONS
45CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer cell biologyPredictive and prognostic markersMolecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 25, 2025
WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response.

Rinskje B Tjeerdsma, Timothy F Ng, Maurits Roorda

|May 03, 2024
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer.

Daan G Knapen, Sara Hone Lopez, Derk Jan A de Groot

|Oct 05, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.

Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen

|Apr 12, 2022
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.

Jiske F Tiersma, Bernard Evers, Barbara M Bakker

|Nov 21, 2019
Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment.

Ximena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma

Pageof 2